Table 3.
Univariate Cox regression analysis of clinical factor and volume measurement with OS and PFS
| Overall Survival | Progression-free Survival | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p | HR | 95% CI | p | |
| Sex | ||||||
| Female | 1 | 1 | ||||
| Male | 1.18 | 0.69-2.02 | 0.538 | 1.32 | 0.79-2.23 | 0.289 |
| Age | ||||||
| < 50 | 1 | 1 | ||||
| ≥ 50 | 1.54 | 0.83-2.89 | 0.174 | 1.43 | 0.77-2.67 | 0.259 |
| PS | ||||||
| 0 | 1 | 1 | ||||
| 1 or 2 | 2.27 | 1.33-3.86 | 0.003 | 2.45 | 1.46-4.13 | 0.001 |
| Surgery | ||||||
| Partial/Biopsy | 1 | 1 | ||||
| Subtotal | 2.02 | 0.95-4.32 | 0.069 | 0.96 | 0.53-1.73 | 0.881 |
| Total | 1.33 | 0.68-2.60 | 0.409 | 0.70 | 0.33-1.48 | 0.352 |
| Volumetry | ||||||
| PreOp Enhancing tumor | 1.01 | 1.00-1.02 | 0.037 | 1.01 | 1.00-1.02 | 0.041 |
| PreOp T2 abnormality | 1.00 | 1.00-1.01 | 0.276 | 1.00 | 1.00-1.01 | 0.387 |
| PreOp Necrosis | 1.02 | 1.00-1.04 | 0.067 | 1.02 | 1.00-1.05 | 0.021 |
| PreRCT Net-enhancing tumor | 1.02 | 1.01-1.04 | 0.001 | 1.01 | 1.00-1.02 | 0.068 |